City
Epaper

IIT Kanpur study finds how cholesterol-lowering drug Niacin works

By IANS | Updated: March 13, 2024 13:20 IST

Kanpur, March 13 Researchers at the Indian Institute of Technology (IIT) Kanpur in a new study detailed how ...

Open in App

Kanpur, March 13 Researchers at the Indian Institute of Technology (IIT) Kanpur in a new study detailed how cholesterol-lowering drugs like Niacin work at a molecular level.

Niacin is known for its ability to raise levels of “good” cholesterol or high-density lipoprotein cholesterol (HDL) in the body while flushing out the “bad” type or low-density lipoprotein cholesterol (LDL). However, it also raises risks of some skin issues.

"Niacin is a commonly prescribed drug to lower bad cholesterol and triglycerides while increasing good cholesterol. However, in many patients, the drug causes side effects such as skin redness and itching, referred to as a flushing response. This leads to patients stopping their treatment with adverse effects on their cholesterol levels,” said Prof. Arun K. Shukla of the Department of Biological Sciences and Bioengineering, IIT Kanpur, in a statement.

To understand the side effects of Niacin, the team deployed the cutting-edge cryogenic-electron microscopy (cryo-EM) technology. Using the technology, they visualised the key receptor molecule -- Hydroxycarboxylic acid receptor 2 (HCA2) -- which Niacin and other related drugs activate.

The HCA2, also known as the niacin receptor or GPR109A, regulates fat-related and artery-clogging processes in the human body.

When the receptor gets activated, it can make the blood vessels widen. This explains why Niacin leads to some patients experiencing a red, flushing skin reaction.

The findings, published in the journal Nature Communications will lead to the development of new drugs to lower cholesterol with fewer side effects.

“The visualisation of the receptor molecule GPR109A's interaction with Niacin at the molecular level lays the groundwork for creating new drugs that maintain efficacy while minimising undesirable reactions. The study results will also help in developing related drugs for cholesterol and drugs for other conditions such as multiple sclerosis,” Prof. Shukla said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

Other SportsParalympic Committee of India director K.R. Satyanarayan elected as SAPSF president

Other SportsZoravar Sandhu favourably placed after day one of Trap qualifications in Lonato

Entertainment"It's very bizarre": 'Outer Banks' star Madelyn Cline says "people love to pay attention to weight"

CricketENG vs IND, 3rd Test: India Reach 316/5 at Tea on Day 3 at Lord’s; Trail England by 71 Runs

NashikNashik Dengue Surge: City Records 29 Dengue Cases in First Week of July

Health Realted Stories

HealthSugar & oil boards in govt offices, schools ‘excellent step’ for healthy India: Experts

HealthAIIA’s national seminar to explore trends in Ayurvedic surgical practices

HealthIIT Delhi launches MRI research facility to foster innovation in medical imaging

HealthWHO acknowledges India’s efforts in integrating AI in traditional medicine, Ayush

HealthAfrica records over 4,200 cholera, mpox deaths in 2025